SNHG20 was originally identified in hepatocellular carcinoma, localized to 17q25.2, and highly expressed in hepatocellular carcinoma, promoting hepatocellular carcinoma proliferation and migration, and was negatively correlated with patient prognosis [13]. Here, SNHG20 is linked to hepatocellular carcinoma.